Alcon Inc logo

Alcon Inc

2
NYSE:ALC (Switzerland)  
$ 78.77 -0.07 (-0.09%) 10:08 PM EST
40.19
P/B:
1.98
Market Cap:
$ 38.91B
Enterprise V:
$ 42.63B
Volume:
1.12M
Avg Vol (2M):
959.77K
Also Trade In:
Volume:
1.12M
Avg Vol (2M):
959.77K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ALC ( Alcon Inc ) from 2019 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alcon stock (ALC) PE ratio as of Apr 27 2024 is 40.19. More Details

Alcon Inc (ALC) PE Ratio (TTM) Chart

To

Alcon Inc (ALC) PE Ratio (TTM) Historical Data

Total 1217
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Alcon PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-27 40.2 2024-02-23 40.9
2024-04-26 40.2 2024-02-22 41.0
2024-04-25 40.2 2024-02-21 40.7
2024-04-24 40.6 2024-02-20 40.0
2024-04-23 41.2 2024-02-16 39.6
2024-04-22 41.1 2024-02-15 39.7
2024-04-19 40.6 2024-02-14 39.0
2024-04-18 40.0 2024-02-13 38.2
2024-04-17 40.3 2024-02-12 39.5
2024-04-16 40.6 2024-02-09 39.4
2024-04-15 41.4 2024-02-08 39.4
2024-04-12 41.5 2024-02-07 39.2
2024-04-11 42.0 2024-02-06 39.3
2024-04-10 41.9 2024-02-05 38.5
2024-04-09 42.2 2024-02-02 38.3
2024-04-08 42.8 2024-02-01 39.0
2024-04-05 43.3 2024-01-31 38.3
2024-04-04 42.7 2024-01-30 38.6
2024-04-03 42.9 2024-01-29 38.8
2024-04-02 41.7 2024-01-26 38.8
2024-04-01 41.9 2024-01-25 38.9
2024-03-28 42.5 2024-01-24 39.0
2024-03-27 42.5 2024-01-23 39.5
2024-03-26 42.2 2024-01-22 40.3
2024-03-25 42.3 2024-01-19 39.7
2024-03-22 42.7 2024-01-18 39.6
2024-03-21 42.8 2024-01-17 39.0
2024-03-20 43.2 2024-01-16 40.0
2024-03-19 43.2 2024-01-12 40.8
2024-03-18 42.9 2024-01-11 40.7
2024-03-15 43.4 2024-01-10 40.9
2024-03-14 43.8 2024-01-09 39.1
2024-03-13 44.6 2024-01-08 39.5
2024-03-12 45.0 2024-01-05 38.3
2024-03-11 45.0 2024-01-04 38.4
2024-03-08 44.5 2024-01-03 38.2
2024-03-07 44.4 2024-01-02 39.3
2024-03-06 43.8 2023-12-29 39.9
2024-03-05 43.4 2023-12-28 39.8
2024-03-04 43.8 2023-12-27 86.6
2024-03-01 44.3 2023-12-26 86.1
2024-02-29 43.1 2023-12-22 85.7
2024-02-28 43.7 2023-12-21 85.3
2024-02-27 41.4 2023-12-20 83.0
2024-02-26 41.1 2023-12-19 84.0

Alcon Inc (ALC) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.